Delivery Order SPE2DE24DA017-SPE2D625F3USN
- Not listed
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $8,250.00 for the Arthrex ACP Double Syringe System on September 15, 2025. This fixed-price delivery order with economic price adjustment is scheduled for ultimate completion on September 18, 2025, and will be performed at the company's Naples, FL facility. The award was issued by the Defense Logistics Agency's Medical Supply Chain, a...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $24,750 fixed-price delivery order with economic price adjustment for the Arthrex ACP Double Syringe System on September 8, 2025, with an ultimate completion date of September 11, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain without a set-aside designation, reflecting Arthrex's competitive strength in the federal marketplace. The product will be...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, has been awarded a delivery order valued at $9,900 for the Arthrex ACP Double Syringe System by the Defense Logistics Agency's Medical Supply Chain. This fixed-price delivery order with economic price adjustment was issued on September 3, 2025, with an ultimate completion date of September 17, 2025. The award represents a non-set-aside competitive procurement and will be...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,475 on August 6, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order with economic price adjustment is scheduled for completion by August 11, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain. The contract carries no...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,665.20 for the Arthrex ACP Double Syringe System on April 24, 2025. This fixed-price contract with economic price adjustment carries an ultimate completion date of April 29, 2025, and will be performed in Naples, Florida. The award was issued by the Defense Logistics Agency's Medical Supply Chain to support the government's orthopedic medical device needs,...
- Arthrex Inc., a Naples, Florida-based orthopedic medical technology leader, was awarded a $19.8K delivery order by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by September 8, 2025, and represents the final delivery location as Naples, FL. The award carries no set-aside designation, reflecting Arthrex's competitive...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $8,250 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, for the Arthrex ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 7, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $4,950 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on September 18, 2025, for the Arthrex ACP Double Syringe System. This delivery order, with an ultimate completion date of September 23, 2025, was awarded without a set-aside designation, reflecting Arthrex's strong competitive standing in the federal orthopedic medical device marketplace. The...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,475.00 on May 16, 2025, for the ARTHREX ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions is scheduled for completion by May 21, 2025. The award carries no set-aside designation, reflecting Arthrex's strong competitive standing in the federal marketplace. The Medical Supply Chain, operating under the...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, was awarded a delivery order valued at $3,300 on September 9, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order with economic price adjustment features an ultimate completion date of September 12, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Medical Supply Chain. The contract is not set aside for any...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F3USNDelivery Order
Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $9,900 on September 18, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order with economic price adjustment has an ultimate completion date of September 23, 2025, and represents work performed at Arthrex's Naples, Florida facility. The award was issued without a set-aside designation, reflecting the company's competitive standing in the federal marketplace for orthopedic medical devices. The delivery order was issued under the Defense Logistics Agency's Medical Supply Chain function and represents one of multiple task orders Arthrex has received under its large Indefinite Delivery Contract (SPE2DE24D0020) valued at $471.0 million and running through September 1, 2029. This IDC arrangement enables Veterans Affairs medical centers and Department of Defense facilities nationwide to procure Arthrex's comprehensive portfolio of orthopedic solutions, including surgical implants, arthroscopic instruments, and specialized surgical systems. The ACP Double Syringe System delivery order supports the agency's mission to provide advanced orthopedic medical technologies to veterans and military personnel requiring minimally invasive surgical solutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 9/18/25 |